Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/14/2025

High-Intensity Statin Therapy in Southeast Asian Patients

Introduction to Statin Therapy

  • For Southeast Asian patients requiring high-intensity statin therapy, the American Heart Association recommends starting with atorvastatin 40 mg daily or rosuvastatin 20 mg daily, with careful monitoring for side effects 1, 2
  • High-intensity statin therapy is defined as treatment that lowers LDL-C by ≥50% from baseline, according to the American College of Cardiology 1, 2
  • The American Heart Association recommends atorvastatin 40 mg daily (can be titrated to 80 mg if needed) for Southeast Asian patients requiring high-intensity statin therapy 1, 2
  • The American Heart Association also recommends rosuvastatin 20 mg daily (can be titrated to 40 mg if needed) for Southeast Asian patients requiring high-intensity statin therapy 1, 2

Considerations for Initiating High-Intensity Statin Therapy

  • Patients with established ASCVD or multiple risk factors benefit most from high-intensity statins, according to the American Diabetes Association 3
  • For patients >75 years, the American Diabetes Association recommends starting with moderate-intensity statin therapy 3
  • For diabetic patients aged 40-75 years with additional ASCVD risk factors, the American Diabetes Association recommends high-intensity statin therapy to reduce LDL-C by ≥50% and target an LDL-C goal of <70 mg/dL 3

Monitoring and Adverse Effects

  • The American Diabetes Association recommends checking lipid panel 4-12 weeks after initiating therapy to assess response 3
  • High-intensity statins carry a 36% relative increase in new-onset diabetes compared to placebo (absolute annual excess of 1.27%), according to The Lancet Diabetes and Endocrinology 5
  • Monitor glucose levels in at-risk patients, according to The Lancet Diabetes and Endocrinology 5

Combination Therapy and Alternative Dosing

  • For very high-risk ASCVD patients not achieving LDL-C goals on maximum tolerated statin therapy, the American Diabetes Association recommends considering adding ezetimibe 3
  • While some earlier guidelines suggested lower statin doses for Asian populations in general, more recent evidence supports using standard doses in South Asian patients specifically, according to the American Heart Association 2